Induction chemo-immunotherapy followed by chemo-radiotherapy and immunotherapy maintenance in stage III NSCLC (APOLO): a phase 2 trial

Journal:

Nature Communications

Published:

2025-12-23

DOI:

10.1038/s41467-025-66097-w

Affiliations:

17

Authors:

29

Go to article

Institutions	Authors	Share
Hospital Universitario Puerta de Hierro Majadahonda, UAM, Spain	6.000000	0.21
Hospital Universitario Lucus Augusti, Spain	3.000000	0.10
Hospital General Universitario de Elche, Spain	3.000000	0.10
Corporació Sanitària Parc Taulí (CSPT), Spain	2.000000	0.07
Hospital Universitario A Coruña (CHUAC), Spain	2.000000	0.07
Hospital Universitario HM Sanchinarro, Spain	2.000000	0.07
OSI Bilbao-Basurto, Spain	1.000000	0.03
Hospital Universitario de Jaén, Spain	1.000000	0.03
Consorci Hospital General Universitario de Valencia (CHGUV), Spain	1.000000	0.03
Hospital Clínico Universitario de Valencia, Spain	1.000000	0.03
Complexo Hospitalario Universitario de Ourense (CHUO), Spain	1.000000	0.03
Hospital de la Santa Creu i Sant Pau, Spain	1.000000	0.03
Hospital Clínico Universitario de Valladolid (HCUValladolid), Spain	1.000000	0.03
Hospital Universitario Insular de Gran Canaria, Spain	1.000000	0.03
Biomedical Research Institute of Girona (IDIBGI), Spain	1.000000	0.03
Hospital Universitario Severo Ochoa, Spain	1.000000	0.03
Hospital Universitari Son Espases, Spain	1.000000	0.03

Interested in Oncology and Carcinogenesis?